Improving access to clinical trials
Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to be part of one.
Expanding trial access – ICR report
Our 2021 report, Clinical trials in cancer, reveals the impact of the Covid-19 pandemic on cancer trials and highlights longstanding barriers to expanding clinical trial access to more people with cancer. But Covid-19 also offers clues to a recovery that can get new treatments to cancer patients more quickly.
News: Cancer trial recruitment drops by 60 per cent during pandemic
The number of cancer patients entering clinical trials has plummeted during the pandemic – denying many thousands the latest treatment options and delaying drug development. Here, cancer experts set out their findings about the barriers to carrying out clinical trials in the UK and proposals for boosting participation.Latest ICR News
A visionary research leader, ally and mentor - Professor Paul Workman steps down as CEO
As Professor Paul Workman steps down as Chief Executive of The Institute of Cancer Research, London, colleagues from the ICR and beyond share memories of and reflections on his impact in cancer research.
The future of ovarian cancer: innovation, treatment and hope
Ovarian cancer is often diagnosed late, making it difficult to treat. But innovative research at The Institute of Cancer Research, London, is changing how we think about managing this complex and hard-to-treat disease. Robbie Lockyer speaks to molecular pharmacology expert and medical oncologist Professor Udai Banerji to find out more about therapeutic research strategies.
ICR joins £10million AI project to help identify individual cancer risk
Doctors could soon be able to better predict an individual patient’s chances of getting cancer and offer them personalised detection and prevention strategies, thanks to a new research project co-led by scientists at The Institute of Cancer Research, London.
Innovative imaging study confirms feasibility of using smaller target areas in radiotherapy for early-stage glottic cancer
Scientists have successfully used real-time MRI to demonstrate that swallowing causes minimal motion of the larynx, known as the voice box, in people undergoing a radiotherapy session for cancer in this part of the body.